Aurobindo Pharma Ltd

Submission of the revised presentation that would be used in the Investors/ Analysits call on Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31 2025 to be held today i.e February 10 2026 at 8.30 a.m.